A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.

Background: Cryptococcal meningitis is a leading cause of death in HIV-infected patients. International treatment guidelines recommend induction therapy with amphotericin B and flucytosine. This antifungal combination is most effective, but unfortunately flucytosine is expensive and unavailable wher...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngan, Nguyen Thi Thuy, Mai, Nguyen Thi Hoang, Tung, Nguyen Le Nhu, Lan, Nguyen Phu Huong, Tai, Luong Thi Hue, Phu, Nguyen Hoan, Chau, Nguyen Van Vinh, Binh, Tran Quang, Hung, Le Quoc, Beardsley, Justin, White, Nicholas, Lalloo, David, Krysan, Damian, Hope, William, Geskus, Ronald, Wolbers, Marcel, Nhat, Le Thanh Hoang, Thwaites, Guy, Kestelyn, Evelyne, Day, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381443/
https://www.ncbi.nlm.nih.gov/pubmed/30801037
http://dx.doi.org/10.12688/wellcomeopenres.15010.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381443/
https://www.ncbi.nlm.nih.gov/pubmed/30801037
http://dx.doi.org/10.12688/wellcomeopenres.15010.1

Ejemplares similares